Abstract: Coatings, coating systems and coating methods for skis and snowboards are provided. The coatings may be lubricious coatings including one or more hydrophobic compounds, adhesion agents, shape memory polymers, free-radical initiators, and/or carrying solvents. Batch and continuous processing systems for performing the methods of coating and/or curing of such hydrophobic coatings are also disclosed.

Abstract: A complex rehabilitation technology system includes a frame and a complex rehabilitation technology device. This frame is movable between a collapsed carriable position and an expanded support position to facilitate portability or storage. The complex rehabilitation technology device is coupled to the frame. And, the complex rehabilitation technology device is configured to be operable when the frame is in the expanded support position. The complex rehabilitation technology system can be portable (e.g., configured for one-handed carrying).

Abstract: A therapeutic gas delivery system with at least one gas supply subsystem is disclosed. The at least one gas supply subsystem may include a gas source coupling configured to receive a therapeutic gas source and form a fluid flow connection with the therapeutic gas source, a therapeutic gas delivery system controller, and one or more display(s) configured to be in communication over a communication path with the therapeutic gas delivery system controller. The display may be configured to display a graphical, illustrative, or numerical indicator of one or more flow or system parameters.

Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system.

Abstract: An all mechanically controlled, non-venting pressure control system for liquid hydrogen and liquid oxygen cryogenic tanks that requires no electrical control while managing disparate, non-stoichiometric reactant boil-off rates is provided. The pressure control system allows for the passive and repeatable stoichiometric consumption of hydrogen and oxygen boil-off from cryogenic tanks to form liquid water, while preventing the liquid hydrogen and liquid oxygen cryogenic tanks from overpressurizing and venting to the external environment. More particularly, in response to an overpressure condition in a first reactant reservoir, a backpressure regulator is opened, providing the overpressure first reactant to a fuel cell or other consumer, and providing a pilot signal to open a supply line from a second reactant reservoir to the consumer. Whether the second reactant is supplied from the second reactant reservoir as gas or a liquid is determined based on the pressure within the second reactant reservoir.

Abstract: A system for manufacturing boiler tubes includes a first spindle for receiving a first tube having a first weld preparation, a second spindle for receiving a second tube having a second weld preparation, the first spindle and the second spindle being rotatable synchronously, and a welding device having a first weld head. The welding device is configured to automatically weld the first tube to the second tube according to a control routine stored in memory to produce a boiler tube.

Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system.

Abstract: Methods and systems for automatically resolving computerized electronic communication anomalies are disclosed herein. The system can include a memory including an error database containing information identifying a plurality of previous detected errors and configuration information associated with those errors. The system can include a plurality of user devices. Each of these plurality of user devices can include: a first network interface to exchange data via the communication network; and a first I/O subsystem to convert electrical signals to user interpretable outputs via a user interface. The system can include a server that can: receive an indication of the initiation of electronic communication; receive an electrical signal including attribute information; receive an error message; identify a trend in error messages; and provide an error solution if a trend is identified.

Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system.

Abstract: An ophthalmic imaging system provides an automatic focus mechanism based on the difference of consecutive scan lines. The system also provides of user selection of a focus point within a fundus image. A neural network automatically identifies the optic nerve head in an FA or ICGA image, which may be used to determine fixation angle. The system also provides additional scan tables for multiple imaging modalities to accommodate photophobia patients and multi-spectrum imaging options.

Abstract: A complex rehabilitation technology system includes a frame and a complex rehabilitation technology device. This frame is movable between a collapsed carriable position and an expanded support position to facilitate portability or storage. The complex rehabilitation technology device is coupled to the frame. And, the complex rehabilitation technology device is configured to be operable when the frame is in the expanded support position. The complex rehabilitation system can be portable (e.g., configured for one-handed carrying).

Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system.

Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system.

Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system.

Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system.

Abstract: Improvements in data security and privacy may be realized by receiving a service request including a social range and a requestor identity; mining a first social network to create a social graph of entities within the social range of the requestor identity, wherein the entities are represented by nodes in the social graph linked to a requestor via one or more edges, wherein a number of edges used to link a given entity to the requestor does not exceed the social range; determining whether the social graph includes at least one person matching personnel included in an organizational chart; and in response to determining that the social graph includes no persons matching the personnel included in the organizational chart, transmitting an acceptance response from a provider-side system to a client-side system.

Abstract: Disclosed herein is a system, method, and computer program product for automatic blocking of audible, sensitive data. Incoming audio is converted into text and analyzed for sensitive information. Based on the detection of sensitive information from a source, a recipient is blocked from receiving the audible sensitive information.

Abstract: The present invention features solid pharmaceutical compositions comprising Compound 1 and Compound 2. In one embodiment, the solid pharmaceutical composition includes (1) a first type of film-coated granules which comprise 50 mg of Compound 1, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion; and (2) a second type of film-coated granules which comprise 20 mg of Compound 2, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion.

Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system.

Abstract: Methods and systems for automatically resolving computerized electronic communication anomalies are disclosed herein. The system can include a memory including an error database containing information identifying a plurality of previous detected errors and configuration information associated with those errors. The system can include a plurality of user devices. Each of these plurality of user devices can include: a first network interface to exchange data via the communication network; and a first I/O subsystem to convert electrical signals to user interpretable outputs via a user interface. The system can include a server that can: receive an indication of the initiation of electronic communication; receive an electrical signal including attribute information; receive an error message; identify a trend in error messages; and provide an error solution if a trend is identified.